| Citation: | TANG Yajie, WANG Zhanyuan, SONG Lijie, LU Guoyu, LIU Cheng, TAO Yanyan. Predictive value of HBP, IL-18 combined with IL-6 for disease severity and prognosis in sepsis[J]. Chinese Journal of General Practice, 2025, 23(7): 1115-1118. doi: 10.16766/j.cnki.issn.1674-4152.004077 |
| [1] |
ZHANG Y Y, NING B T. Signaling pathways and intervention therapies in sepsis[J]. Signal Transduct Target Ther, 2021, 6(1): 407. DOI: 10.1038/s41392-021-00816-9.
|
| [2] |
SUN B S, LEI M X, ZHANG J Q, et al. Acute lung injury caused by sepsis: how does it happen?[J]. Front Med (Lausanne), 2023, 10: 1289194. DOI10.3389/fmed. 2023.1289194.
|
| [3] |
BARICHELLO T, GENEROSO J S, SINGER M, et al. Biomarkers for sepsis: more than just fever and leukocytosis: a narrative review[J]. Crit Care, 2022, 26(1): 14. DOI: 10.1186/s13054-021-03862-5.
|
| [4] |
CONG S, MA T G, DI X, et al. Diagnostic value of neutrophil CD64, procalcitonin, and interleukin-6 in sepsis: a meta-analysis[J]. BMC Infect, 2021, 21(1): 384. DOI: 10.1186/s12879-021-06064-0.
|
| [5] |
OTHMAN A, SEKHERI M, FILEP J G. Roles of neutrophil granule proteins in orchestrating inflammation and immunity[J]. FEBS J, 2022, 289(14): 3932-3953. doi: 10.1111/febs.15803
|
| [6] |
冯立伟, 王婕莹, 王洪亮, 等. 肝素结合蛋白在重症患者中的临床应用[J]. 中国急救医学, 2023, 43(7): 579-584.
FENG L W, WANG J Y, WANG H L, et al. Clinical application of heparin-binding protein in severe patients[J]. Chinese Journal of Critical Care Medicine, 2023, 43(7): 579-584.
|
| [7] |
李璐, 李文强, 胡念丹, 等. 血清IL-18水平评估脓毒症患者病情严重程度的价值[J]. 中国急救复苏与灾害医学杂志, 2022, 17(2): 221-224, 229.
LI L, LI W Q, HU N D, et al. The value of serum IL-18 level in evaluating the severity of sepsis[J]. China Journal of Emergency Resuscitation and Disaster Medicine, 2022, 17(2): 221-224, 229.
|
| [8] |
EVANS L, RHODES A, ALHAZZANI W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med, 2021, 49(11): 1181-1247.
|
| [9] |
PIERRAKOS C, VELISSARIS D, BISDORFF M, et al. Biomarkers of sepsis: time for a reappraisal[J]. Crit Care, 2020, 24(1): 287. DOI: 10.1186/s13054-020-02993-5.
|
| [10] |
IHIM S A, ABUBAKAR S D, ZIAN Z, et al. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment[J]. Front Immunol, 2022, 13: 919973. DOI: 10.3389/fimmu.2022.919973.
|
| [11] |
曹轮飞, 程亚辉, 赵振东. 脓毒症患者血清PCT和IL-10及IL-18水平及其预后价值分析[J]. 医药论坛杂志, 2023, 44(16): 35-39.
CAO L F, CHENG Y H, ZHAO Z D, et al. Analysis of serum levels of PCT, IL-10, and IL-18 and their prognostic values in patients with sepsis[J]. Journal of Medical Forum, 2023, 44(16): 35-39.
|
| [12] |
WU Y L, YO C H, HSU W T, et al. Accuracy of heparin-binding protein in diagnosing sepsis: a systematic review and meta-analysis[J]. Crit Care Med, 2021, 49(1): e80-e90. doi: 10.1097/CCM.0000000000004738
|
| [13] |
景丽丽, 张玉伟, 刘彬, 等. 血清HMGB1、HBP、IL-10水平预测脓毒症预后的临床价值[J]. 中华医院感染学杂志, 2023, 33(1): 31-34.
JING L L, ZHANG Y W, LIU B, et al. Clinical value of serum HMGB1, HBP and IL-10 in prediction of prognosis of patients with sepsis[J]. Chinese Journal of Nosocomiology, 2023, 33(1): 31-34.
|
| [14] |
FISHER J, KAHN F, WIEBE E, et al. The dynamics of circulating heparin-binding protein: implications for its use as a biomarker[J]. J Innate Immun, 2022, 14(5): 447-460. doi: 10.1159/000521064
|
| [15] |
李璐, 吴优, 史娟娟. 血清PTX3、HBP、PGRN水平与产褥期细菌感染所致脓毒症的关联性分析[J]. 淮海医药, 2023, 41(4): 352-355.
LI L, WU Y, SHI J J, et al. Expression of PTX 3, HBP and PGRN in patients with sepsis induced by puerperal bacterial infection and its clinical significance[J]. Journal of Huaihai Medicine, 2023, 41(4): 352-355.
|
| [16] |
KATSAROS K, RENIERIS G, SAFARIKA A, et al. Heparin binding protein for the early diagnosis and prognosis of sepsis in the emergency department: the prompt multicenter study[J]. Shock, 2022, 57(4): 518-525. doi: 10.1097/SHK.0000000000001900
|
| [17] |
高怡宁, 李明晖. 血清标志物在细菌及病毒性脓毒症鉴别诊断中的价值[J]. 浙江医学, 2022, 44(1): 21-24.
GAO Y N, LI M H. Value of serum markers in differential diagnosis of bacterial and viral sepsis[J]. Zhejiang Medical Journal, 2022, 44(1): 21-24.
|
| [18] |
SCHMIDT-ARRAS D, ROSE-JOHN S. Endosomes as signaling platforms for IL-6 family cytokine receptors[J]. Front Cell Dev Biol, 2021, 9: 688314. DOI: 10.3389/fcell.2021.688314.
|
| [19] |
牛凯旋, 吴淑璐, 刘成, 等. 血清淀粉样蛋白A和白细胞介素-6对脓毒症诊断及病情严重程度评估的临床价值[J]. 中华全科医学, 2022, 20(9): 1484-1487. doi: 10.16766/j.cnki.issn.1674-4152.002629
NIU K X, WU S L, LIU C, et al. Clinical value of serum amyloid A and interleukin-6 in the diagnosis and severity evaluation of sepsis[J]. Chinese Journal of General Practice, 2022, 20(9): 1484-1487. doi: 10.16766/j.cnki.issn.1674-4152.002629
|
| [20] |
HIRANO T. IL-6 in inflammation, autoimmunity and cancer[J]. Int Immunol, 2021, 33(3): 127-148. doi: 10.1093/intimm/dxaa078
|
| [21] |
段莉莉, 段榆琳, 刘艳. 脓毒症患者白细胞计数、血清C反应蛋白、肝素结合蛋白、降钙素原表达及与病情进展及预后关系[J]. 临床和实验医学杂志, 2024, 23(6): 589-592.
DUAN L L, DUAN Y L, LIU Y, et al. Expression of white blood cell count, serum C-reactive protein, heparin binding protein, and procalcitonin in sepsis patients and their relationship with disease progression and prognosis[J]. Journal of Clinical and Experimental Medicine, 2024, 23(6): 589-592.
|